Ezio Merler 2026-11-05
Ezio Merler coauthored the 1971 study of angiogenic activity isolated from tumours, alongside Judah Folkman, Charles Abernathy and Gretchen Williams.[ref] The investigators coupled biochemical separation with a biological response, asking whether separated material could induce new capillaries.
This is the logic of bioassay-guided fractionation: a fraction is interesting because a reproducible biological effect follows it through the separation procedure. An active fraction need not be a single pure molecule. The historical preparation should therefore not be identified retrospectively with vascular endothelial growth factor merely because both concern angiogenesis.
An original example distinguishes recovery from enrichment. Suppose a starting extract contains 100 arbitrary units of angiogenic activity in 20 milligrams of protein. Its activity per milligram is . A later fraction contains 40 units in 2 milligrams, giving units per milligram. The process has achieved fourfold enrichment with 40 percent activity recovery. Neither number establishes chemical purity. Here the activity units are assumed additive for illustration; an ordinal visual score cannot automatically be treated as an additive biochemical quantity.
New blood vessels in a healing wound arise chiefly by angiogenesis: sprouts grow from surviving blood vessels, unite into patent channels, and mature within the granulation tissue. Blood does not simply excavate permanent channels in a shapeless clot.
The initial wound contains a provisional extracellular matrix, including fibrin, with inflammatory biological cells and later fibroblasts. Local hypoxia and signals from injured tissue and inflammatory biological cells stimulate surviving endothelium. In modern molecular terms, vascular endothelial growth factor is an important stimulus. This molecular account explains the process today; it is not evidence that the examiner expected the named signalling molecule in 1867.[ref]
The sequence is as follows:
This sequence separates growth of the cellular lining, formation of the channel, establishment of flow, and stabilization. These are different experimental observations, even though they overlap in time.[ref]
An instructive anatomical investigation follows the wound at successive stages. Thin sections show solid sprouts, lumina lined by endothelium and their relation to the old blood vessels. Injection of a suitable casting material into the supplying blood vessels, followed by examination of the cast, reveals which channels are continuous with the circulation. The corneal wound example in the modern textbook uses resin injection and scanning electron microscopy of the resulting casts. Seeing an cord of endothelium and demonstrating a perfused loop therefore answer different questions.[ref]
The essential repair process is sprouting, lumen formation, connection and maturation. The contrast with embryonic vasculogenesis, assembly from vascular precursors, helps define angiogenesis; it does not require assuming that every new blood vessel in an adult wound has an identical cellular history.
Tumour angiogenesis 2026-11-05
Tumour angiogenesis is the growth of new blood vessels from pre-existing vessels in response to a tumour and its surrounding tissue. It supplies a route for oxygen and nutrients to reach growing cells. Vessel formation and effective perfusion are distinct: a vascular image alone does not measure the delivery of oxygen to every part of a tumour.
A foundational experiment by Judah Folkman, Ezio Merler, Charles Abernathy and Gretchen Williams tested tumour-derived material in a rat dorsal air sac assay. A membrane wick delivered separated material locally; after 48 hours the investigators inspected the vascular response with a stereoscope and took tissue sections. A wick without the active preparation provided a negative control. The response was graded from 0 to 5+, rather than measured as an absolute endothelial cell count.[ref] This connected an isolated preparation to a reproducible biological effect. It did not identify a unique modern molecule or establish that inhibiting one signal would cure all cancers.
An original diffusion model explains why access to vessels matters. Approximate a vessel-free tumour as a sphere of radius with uniform oxygen consumption per unit volume per unit time. Let be a constant diffusion coefficient and fix the surface oxygen concentration at . At steady state, the diffusion equation with consumption and spherical symmetry becomes
Finiteness at the centre removes the singular integration term. Integrating again and imposing gives
If a stipulated threshold is required to avoid hypoxia, the model predicts
For illustration, take , and . The limiting radius is approximately , or . These are chosen model inputs, not measurements from the historical study or a universal size limit. Quadrupling consumption halves the limiting radius. A predicted negative concentration indicates failure of the assumed uniformly consuming viable sphere, not physically negative oxygen.
The calculation isolates a transport constraint; it does not model vessel branching, changing consumption or delivery by flowing blood. Signals such as vascular endothelial growth factor can influence endothelial cells, but their action and the resulting perfusion require biological measurements beyond this spherical model.
Vascular endothelial growth factor Created 2026-10-31 Updated 2026-11-05
Vascular endothelial growth factor, commonly abbreviated VEGF, denotes a family of signaling proteins with major roles in vascular development and remodeling. Binding to the appropriate receptors changes endothelial-cell behavior, including growth, survival or movement.
Its effect depends on location, timing and receptor context. A spatially organized signal can guide construction of a network, whereas simply increasing the concentration everywhere need not create correctly patterned functional blood vessels.
VEGF Created 2026-10-20 Updated 2026-11-05
Vascular endothelial growth factor, a family of signals that regulate vascular development and function, including angiogenic responses in tumours.